Table IV. mCs in the spleen of S. agalactiae–resistant and S. agalactiae–susceptible groups.

Sample	C (n [%])	CG (n [%])	CHG (n [%])	CHH (n [%])
K5h-1	210,462,338 (100)	194,209,887 (92.29)	4,216,077 (2.00)	12,036,374 (5.71)
K5h-2	153,833,084 (100)	142,783,771 (92.82)	2,910,671 (1.89)	8,138,642 (5.29)
K5h-3	225,897,136 (100)	210,304,976 (93.01)	4,182,918 (1.85)	11,409,242 (5.05)
Y5h-1	186,761,315 (100)	172,040,367 (92.12)	3,866,816 (2.07)	10,854,132 (5.81)
Y5h-2	165,841,768 (100)	153,986,363 (92.85)	3,139,123 (1.89)	8,716,282 (5.26)
Y5h-3	192,855,270 (100)	178,015,458 (92.31)	3,941,047 (2.04)	10,898,765 (5.65)